Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
12/2003
12/09/2003US6660861 Use of dichloromethane under solid-liquid phase transfer catalysis, which can behave both as solvent and a reactant when it serves as a source for C-1 unit for amino-alkylation of 10-hydroxy-4- (S)camptothecin
12/09/2003US6660740 Sorbitol dehydrogenase inhibitors
12/09/2003US6660731 Pyrazole compounds useful as protein kinase inhibitors
12/09/2003US6660727 Photochromic heterocyclically anellated indenochromene compounds
12/09/2003CA2103707C Treatment of non-small cell lung carcinoma
12/04/2003WO2003099825A1 Synthesis of polycyclic quinolines
12/04/2003WO2003099824A1 R-enantiomers of pyranoindole derivatives against hepatitis c
12/04/2003WO2003099823A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099822A2 1,2-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099821A1 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
12/04/2003WO2003099814A1 Calcium receptor modulating agents
12/04/2003WO2003099275A1 Method for the use of pyranoindole derivatives to treat infection with hepatitis c virus
12/04/2003WO2003099274A1 Hepatitis c virus inhibitors
12/04/2003WO2003066604A3 Novel aryl- and heteroarylpiperazines
12/04/2003WO2003050122A3 Mitotic kinesin inhibitors
12/04/2003WO2003010138A3 Piperidine derivatives as antibacterial agents
12/04/2003WO2002080846A3 Epothilone derivatives and methods for making and using the same
12/04/2003WO2002073208A3 Anti-epileptogenic agents
12/04/2003US20030225269 Inhibitors of interleukin-1beta converting enzyme
12/04/2003US20030225152 Such as 3-phenylaminomethylene-1,3-dihydroindol-2-one; use treating cancer, blood vessel proliferative disorders, fibrotic disorders, mesangial cell proliferative disorders and metabolic diseases
12/04/2003US20030225150 Method of using a COX-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia
12/04/2003US20030225147 Inhibit activity of protein kinases; for tumor growth, angiogenesis, viral infection, autoimmune disease or neurodegenerative disorder
12/04/2003US20030225128 For treating conditions such as erectile dysfunction, cardiovascular disorders, male or female sexual dysfunction, diabetes mellitus, and gastrointestinal disorders
12/04/2003US20030225116 Substituted 4-phenyl-1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridine
12/04/2003US20030225113 E.g., tert-Butyl-5-amino-2-methylthio-4-(3-methoxyphenyl)-quinazoline-6 -carboxamide; used in fertility regulation therapies.
12/04/2003US20030225106 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer
12/04/2003US20030225105 New linear cyclic ureas
12/04/2003US20030225098 Pyrazolopyrmidine, isoxazolopyridimidine and furopyrimidine analogs; e.g, 3-(4-nitrophenyl)isoxazolo(5,4-d)pyrimidin-4-amine
12/04/2003US20030225097 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by np y5 receptor
12/04/2003US20030225081 Pyridazinones and triazinones and medicinal use thereof
12/04/2003US20030225070 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
12/04/2003US20030225061 Protease inhibitors
12/04/2003US20030225060 Acylated piperidine derivatives as melanocortin-4 receptor agonists
12/04/2003US20030225059 Cyclohexyl derivatives and their use as therapeutic agents
12/04/2003US20030225057 3-Benzoazepine derivatives
12/04/2003US20030224391 Rigidized trimethine cyanine dyes
12/04/2003CA2487017A1 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003CA2487015A1 1,2-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003CA2486056A1 R-enantiomers of pyranoindole derivatives against hepatitis c
12/04/2003CA2485972A1 Method for the use of pyranoindole derivatives to treat infection with hepatitis c virus
12/03/2003EP1366050A2 Condensed pyrazindione derivatives as pde inhibitors
12/03/2003EP1117659B1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
12/03/2003CN1460104A Pyridoarylphenyl oxazolidinone antibacterials and related compositions and methods
12/03/2003CN1129597C Heterocyclic compounds and antitumor agent containing same as active ingredient
12/03/2003CN1129578C Tetrahydrobenzindole derivs
12/02/2003US6656964 Reducing levels of tumor necrosis factor alpha; inhibition of undesireable levels of matrix metalloproteinases
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
12/02/2003US6656950 Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine
12/02/2003US6656949 4-anilinofuro [3,2-c] quinoline derivatives, and preparation processes and uses of the same
12/02/2003US6656947 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinazoline
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
12/02/2003CA2284446C New cyclic cycloalkylene chain derivatives, their preparation process and pharmaceutical compounds containing them
11/2003
11/27/2003WO2003098617A2 Optical storage media comprising pentacyclic xanthylium dyes
11/27/2003WO2003097806A2 Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/27/2003WO2003097648A1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the prepartion thereof
11/27/2003WO2003097646A1 Acyl bicyclix derivatives of pyrrol
11/27/2003WO2003097642A1 Anti-tumour polycyclic carboxamides
11/27/2003WO2003097609A1 N-substituted tricyclic 3-aminopyrazoles as pdfg receptor inhibitors
11/27/2003WO2003097356A1 Camptothecin derivatives and polymeric conjugates thereof
11/27/2003WO2003096782A2 Process for preparing maytansinol
11/27/2003WO2003065983A3 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/27/2003WO2003053354A3 Fused cyclic modulators of nuclear hormone receptor function
11/27/2003WO2003024899A3 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE)
11/27/2003WO2003022852A3 Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
11/27/2003US20030220499 Novel spiro compounds
11/27/2003US20030220496 3-(optionally hydroxyl)-4-(cyclopropylcarbonyl)-cumene intermediate
11/27/2003US20030220423 A polymerization catalyst for free radical polymerization of ethylenically unsaturated monomers
11/27/2003US20030220388 Indoline derivatives
11/27/2003US20030220385 Nitrogen compounds such as 1-benzyl-3-(5'-hydroxymethyl-2'-furyl)-6-fluoroindazole, administered as phosphodiesterases inhibitors for prophylaxis of cardiovascular or sexual disorders, or as hypotensive agents
11/27/2003US20030220360 Tricyclic condensed heterocyclic compounds containing o, s in the ring, and atleast one hydroxy group, useful as antiasthmatic drugs
11/27/2003US20030220341 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/27/2003US20030220332 Useful in the treatment of inter alia benign prostatic hyperplasia
11/27/2003US20030220330 Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
11/27/2003US20030220327 Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazephine as HIV reverse transcriptase inhibitors
11/27/2003US20030220320 Ningalin b analogs employable for reversing multidrug resistance
11/27/2003US20030220295 Epothilone derivatives
11/27/2003CA2486097A1 N-substituted tricyclic 3-aminopyrazoles as pdfg receptor inhibitors
11/27/2003CA2485212A1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
11/27/2003CA2485006A1 Camptothecin derivatives and polymeric conjugates thereof
11/27/2003CA2484702A1 Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/26/2003EP1363909A2 Tricyclic androgen receptor modulator compounds
11/26/2003EP1363907A2 Heterocycle carboxamides as antiviral agents
11/26/2003EP1363899A1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
11/26/2003EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363883A1 Hydroxy-substituted n-alkoxy hindered amines and compositions stabilized therewith
11/26/2003EP1363873A2 Peptide deformylase inhibitors
11/26/2003EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1015457B1 1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives as ampa/kainate receptor inhibitors
11/26/2003EP0828487B1 Agents for use against parasitic protozoa
11/26/2003CN1458929A Chemokine receptor binding heterocyclic compounds
11/26/2003CN1458924A Pyridazinones and triazinones and medicinal use thereof
11/26/2003CN1458922A Urea derivative and adhesive-molecule inhibitor containing same as ctive ingredient
11/26/2003CN1128802C Phenyl-substituted cyclic ketoenol and pesticide and herbicide
11/26/2003CN1128797C Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C- linked imidazoles
11/26/2003CN1128790C 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
11/25/2003US6653319 Formulating alkaline supersaturated aqueous solution of lipophilic derivative and solubilizer; acidifying
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/20/2003WO2003095461A1 Halo-alkyl esters of camptothecins and methods of treating cancer using these compounds
11/20/2003WO2003095460A1 Cascade esters of camptothecins and methods of treating cancer using these compounds
1 ... 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 ... 298